High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer
The Prostate2010Vol. 71(3), pp. 281–288
Citations Over TimeTop 10% of 2010 papers
Sarah Minner, Corinna Wittmer, Markus Graefen, Georg Salomon, Thomas Steuber, Alexander Haese, Hartwig Huland, Carsten Bokemeyer, Emre F. Yekebas, Judith Dierlamm, Stefan Balabanov, Ergin Kilic, Waldemar Wilczak, Ronald Simon, Guido Sauter, Thorsten Schlomm
Abstract
Based on the high frequency of PSMA overexpression in all stages and grades of prostate cancer and the high prevalence of PSMA overexpression, it can be speculated that increased PSMA expression may be related with prostate cancer development rather than progression. The known function of PSMA activating cell migration would be in line with the suggested role in cancer progression and the missing association between PSMA overexpression and tumor cell proliferation.
Related Papers
- → Increasing EMMPRIN and matriptase expression in hepatocellular carcinoma: tissue microarray analysis of immunohistochemical scores with clinicopathological parameters(2006)54 cited
- → Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation?(2004)51 cited
- → PRUNE2 and PCA3 expression in paired non-malignant and tumor specimens from radical prostatectomy patients with gleason score 7 prostate cancer.(2017)1 cited
- → MP-16.07 Prognostic Values of AMACR, PSMA, PSCA, EGFR, and Bcl-2 in Patients Undergoing Radical Prostatectomy: A Study with Objective Staining Score of Tissue Microarray(2011)
- Correlation of overexpression of macrophage migration inhibitor factor with clinicopathological features with tissue microarray(2009)